Clinical trial
Determining the Association Between Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Association Between Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 1995
- Completion date
- November 10, 2020
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
addison disease, ankylosing spondylitis, antiphospholipid antibody syndrome, celiac disease, crohn disease, dermatomyositis, graves disease, guillain-barre syndrome, hashimoto thyroiditis, hepatitis, autoimmune, multiple sclerosis, myasthenia gravis, pernicious anemia, polymyalgia rheumatica, polymyositis, primary biliary cirrhosis, psoriasis, raynaud, rheumatoid arthritis, scad, sjögren syndrome, systemic lupus erythematosus, systemic sclerosis, takayasu arteritis, type 1 diabetes mellitus, ulcerative colitis, uveitis, vasculitis, vitiligo